Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaas Poelstra

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Journal of Liposome Research|November 21, 2007
Addressing liver fibrosis with liposomes targeted to hepatic stellate cellsJoanna E Adrian, Klaas Poelstra, Jan A A M Kamps
Molecular Cancer Therapeutics|August 31, 2012
Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growthRuchi Bansal, Tushar Tomar, Arne Ostman, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 7, 2017
WNT-5A regulates TGF-β-related activities in liver fibrosisLeonie Beljaars, Sara Daliri, Christa Dijkhuizen, et al.
Molecular Pharmaceutics|August 2, 2011
Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosisRuchi Bansal, Jai Prakash, Marieke de Ruijter, et al.
The Journal of Gene Medicine|August 5, 2014
Targeted elimination of activated hepatic stellate cells by an anti-epidermal growth factor-receptor single chain fragment variable antibody-tumor necrosis factor-related apoptosis-inducing ligand (scFv425-sTRAIL)Mohammad Arabpour, Klaas Poelstra, Wijnand Helfrich, et al.
Nephron. Physiology|January 31, 2004
Regulation of plasma hemopexin activity by stimulated endothelial or mesangial cellsJola J Kapojos, Klaas Poelstra, Theo Borghuis, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in miceRuchi Bansal, Jai Prakash, Eduard Post, et al.
Biochemical Pharmacology|September 25, 2003
The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissueLeonie Beljaars, Betty Weert, Albert Geerts, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 5, 2012
PEGylation of interleukin-10 improves the pharmacokinetic profile and enhances the antifibrotic effectivity in CCl₄-induced fibrogenesis in miceAdriana Mattos, Alie de Jager-Krikken, Marianne de Haan, et al.
Journal of Drug Targeting|July 11, 2003
The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cellsBarbro N Melgert, Betty Weert, Huub Schellekens, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Journal of Liposome Research|November 21, 2007
Addressing liver fibrosis with liposomes targeted to hepatic stellate cellsJoanna E Adrian, Klaas Poelstra, Jan A A M Kamps
Molecular Cancer Therapeutics|August 31, 2012
Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growthRuchi Bansal, Tushar Tomar, Arne Ostman, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 7, 2017
WNT-5A regulates TGF-β-related activities in liver fibrosisLeonie Beljaars, Sara Daliri, Christa Dijkhuizen, et al.
Molecular Pharmaceutics|August 2, 2011
Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosisRuchi Bansal, Jai Prakash, Marieke de Ruijter, et al.
The Journal of Gene Medicine|August 5, 2014
Targeted elimination of activated hepatic stellate cells by an anti-epidermal growth factor-receptor single chain fragment variable antibody-tumor necrosis factor-related apoptosis-inducing ligand (scFv425-sTRAIL)Mohammad Arabpour, Klaas Poelstra, Wijnand Helfrich, et al.
Nephron. Physiology|January 31, 2004
Regulation of plasma hemopexin activity by stimulated endothelial or mesangial cellsJola J Kapojos, Klaas Poelstra, Theo Borghuis, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in miceRuchi Bansal, Jai Prakash, Eduard Post, et al.
Biochemical Pharmacology|September 25, 2003
The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissueLeonie Beljaars, Betty Weert, Albert Geerts, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 5, 2012
PEGylation of interleukin-10 improves the pharmacokinetic profile and enhances the antifibrotic effectivity in CCl₄-induced fibrogenesis in miceAdriana Mattos, Alie de Jager-Krikken, Marianne de Haan, et al.
Journal of Drug Targeting|July 11, 2003
The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cellsBarbro N Melgert, Betty Weert, Huub Schellekens, et al.
Pageof 8